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Dear Editor,
In transfusion medicine, it can be a challenge to obtain
compatible blood for patients who have clinically important
alloantibodies to high-prevalence antigens. We describe a
case which examples the decision process for autologous
blood deposition in the Dutch health care system.
In September 2006, a 56-year-old man was admitted to
the emergency room after a serious accident. Coagulation
and hematology parameters were in normal range except
for a low hemoglobin of 7.9 g/dL. His blood group was
determined as O, Rhesus D-positive and antibody screening
(DiaMed) was negative. Transfusion anamnesis was also
negative. Two units of packed erythrocytes were
administrated. Eight days later hemoglobin had dropped
to 7.1 g/dL. Upon a negative antibody screening, 2 units
of erythrocytes were transfused. After 20 days, the
patient had to undergo surgery. Now, antibody screening
and identification, using standard and papain enzyme-
treated panels (DiaMed), demonstrated strong positive
reactions with all cells. These results were suggestive
for the presence of an alloantibody against a high-
prevalence antigen. Further serologic and genetic analysis
revealed that C/c and E/e antigens were completely absent on
the surface of the patient's erythrocytes, indicating the
presence of the rare -D-/-D- phenotype [1]. Adsorption and
elution studies revealed the presence of anti-C, -E, -e, -Ce,
and -cE alloantibodies and antibodies against the high-
prevalence antigens of the RhCcEe polypeptide (anti-Rh17
antibodies) [2]. Furthermore, we identified alloantibodies
against Jk
a and Le
a.
Hemolytic transfusion reactions due to anti-Le
a are
rare [3]. Anti-Rh17 [4] and anti-Jk
a antibodies, however,
can lead to massive hemolysis. Therefore, only eryth-
rocytes of donors with the -D- phenotype, negative for
Jk
a, could be selected for transfusion. The -D- haplotype
is rare, ranging in frequency from 0.0005 in Sweden [5]
to 0.0032 in Japan [6], and homozygosity for RHCE-D-
CE hybrid genes appears to account for several examples
of -D- [1]. Worldwide, only two suitable donors were
registered. Since the risk of substantial blood loss was
low, the patient underwent surgery in the absence of
compatible donor erythrocytes. The patient was encour-
aged to donate autologous blood to be stored at the
Sanquin Bank of Frozen Blood (SBFB). In November
2009, the patient was scheduled for coronary artery
bypass graft surgery. It was estimated that, by optimal
use of intraoperative cell salvage, the patient would
maximally need 1 unit of blood. Five weeks before
surgery, the patient's hemoglobin was 15.1 g/dL, allow-
ing preoperative donation of 2 units of fresh blood. In
case of need, frozen units of the SBFB could also be
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DOI 10.1007/s00277-011-1344-7thawed. During surgery in December 2009, 1 unit of
fresh autologous blood and 400 mL of cell salvage blood
was transfused to the patient. Postoperatively the
patient's hemoglobin level was 11.1 g/dL. He was
discharged from the hospital 9 days later.
To date the clinical relevance of the -D- phenotype has
been predominantly described in pregnant women, causing
mild to fatal hemolytic disease of the newborn [4, 7–10].
We describe the successful treatment of a patient with
recurrent need of transfusions despite the presence of
antibodies against the high-prevalence antigens of the
RhCcEe polypeptide combined with anti-Jk
a.
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